Article

Leonard Apt, Jules Stein Eye Founder, dies

 

Leonard Apt, MD, a founding member of the Jules Stein Eye Institute at UCLA and emeritus professor of ophthalmology, died Feb. 1 after a brief illness. He was 90.

Dr. Apt's career was filled with many firsts, including the first physician in the world to become board-certified in both pediatrics and ophthalmology. He also co-developed an antiseptic eye drop, commercially known as Betadine, that substantially reduced the incidence of blindness in children in developing countries. He devoted his career to preventing blindness in children. 

Dr. Apt also invented several diagnostic tests, including the Apt test, which distinguishes between fetal and maternal blood after birth. He was the first to use plastic tubing for blood transfusions. He developed a test that predicts allergy to catgut and collagen sutures prior to surgery and he developed a formula to determined the eyes' proper position under anesthesia.

Dr. Apt joined UCLA in 1961 and founded the first full-time pediatric ophthalmology and strabismus division. He was also co-founder and co-director of the UCLA Center to Prevent Childhood Blindness.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.